| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,623 | 2,965 | 5,523 | 5,210 | | Cost of Revenue | 11,701 | 2,885 | 4,145 | 4,078 | | | Gross Profit | 922 | 80 | 1,378 | 1,132 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,126 | 1,779 | 2,575 | 3,675 | | Non Recurring |
-
| 22,938 |
-
| 3,442 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,012) | (24,637) | (1,197) | (5,985) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,939 | (1,552) | 353 | 3,316 | | Earnings Before Interest And Taxes | 2,735 | (26,189) | (844) | (2,668) | | Interest Expense | 454 | 1,554 | 1,800 | 2,070 | | Income Before Tax | 2,281 | (27,743) | (2,644) | (4,738) | | Income Tax Expense | 1 | (1) | 2 | 43 | | Minority Interest |
-
|
-
|
-
| 1 | | | | Net Income From Continuing Ops | 2,280 | (27,742) | (2,646) | (4,781) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,280 | (27,742) | (2,646) | (4,781) | | Preferred Stock And Other Adjustments |
-
| (1) | 1 |
-
| | | Net Income Applicable To Common Shares | $2,280 | ($27,743) | ($2,645) | ($4,781) |
|
0.26% Nasdaq 
Income Statement
